Orbital and adnexal involvement in sarcoidosis: Analysis of clinical features and systemic disease in 30 cases

American Journal of Ophthalmology

Volumn 151, Issue 6, 2011, Pages

  Demirci, Hakan ^a,b   Christianson, Murray D ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADNEXAL SARCOIDOSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DRUG EFFICACY; EXCISION; EYELID; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LACRIMAL GLAND; LACRIMAL SAC; MALE; OBSERVATIONAL STUDY; ORBIT SARCOIDOSIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SARCOIDOSIS; SYSTEMIC DISEASE; SYSTEMIC THERAPY;

EID: 79957550138     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.12.011     Document Type: Article

References (18)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160(2):736-755.
2. Bresnitz EA and Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev 1983(5);5:124-156. (Pubitemid 14238316)
3. Rybicki BA, Major JM, Popovich M Jr, Mallarik MJ, Iannuzzi MC. Racial difference in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiology 1997;145(3):234-241.
4. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357(21):2153-2165.
5. Newman LS, Rose CS, Maier LA. Sarcoidosis N Engl Med 1997;336(17):1224- 1234.
6. Rybicki BA, Iannuzzi MC. Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med 2007;28(1):22-35. (Pubitemid 46371213)
7. Judson MA. Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. Am J Med Sci 2008;335(1):26-33.
8. Smith JA, Foster CS. Sarcoidosis and its ocular manifestations. Int Ophthalmol Clin 1996;36(1):109-125. (Pubitemid 26116947)
9. Prabhakaran VC, Saeed P, Esmaeli B, et al. Orbital and adnexal sarcoidosis. Arch Ophthalmol 2007;125(12):1657-1662. (Pubitemid 350254880)
10. Obenauf CD, Shaw HE, Syndor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 1978;86(5):648-655. (Pubitemid 9012789)
11. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986;102(3):297-301. (Pubitemid 16054936)
12. Collison JM, Miller NR, Green WR. Involvement of orbital tissues by sarcoid. Am J Ophthalmol 1986;102(3):302-307. (Pubitemid 16054937)
13. Brincker H, Wilbek E. The incidence of malignant tumors in patients with respiratory sarcoidosis. Br J Cancer 1974;29(3):247-251.
14. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999;160(5 Pt 1):1668-1672.
15. Mavrikakis I, Rootman J. Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol 2007;144(5):769-775.
16. Paramothayan NS, Lasserson TJ, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev 2005;18(2):CD001114.
17. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996;51(3):238-247.
18. Hunninghake GW, Gilbert S, Pueringer R, et al. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994;149(4 Pt 1):893-898. (Pubitemid 24108477)